News and Events

We are delighted to announce that Eli Lilly and Company has joined I-ACT for Children as our newest Sustaining Member. Please click the image below for the press release and full details.

We are thrilled to welcome Novartis as our newest sustaining member, click the image below to read the full press release.  

At the recent annual meeting of the Society of Clinical Research Associates (SoCRA), I-ACT for Children’s Lisa Benson and Janelle Allen were honored for their contributions to pediatric clinical trials. Lisa Benson, Vice President of Clinical Research Operations, Quality and Education, was awarded the SoCRA President’s Award for Distinguished Service. The award recognized the impact Ms. Benson’s…

As I-ACT for Children continues to grow, we are again in need for talented individuals to join our team. If you are interested in joining a group of hard-working, dedicated individuals focused on improving pediatric healthcare, please review the open positions found below. Medical Director Clinical Project Manager Senior Administrative Assistant   All applications should…

The Institute for Advanced Clinical Trials for Children (I-ACT for Children) is pleased to welcome Laura Gordon as Chief Executive Officer. Ms. Gordon is a highly experienced executive leader with expertise in health policy and communications, organizational development and stakeholder engagement in the public and private healthcare sectors. She most recently was General Manager of…

Recruiting a sufficient number of participants to complete a pediatric trial is often a major limitation within an efficacious study. To combat this issue, the Institute for Advanced Clinical Trials for Children (I-ACT for Children) is constructing a network of hospital centers and university sites that have demonstrated the appropriate resources to carry out pediatric…

The Institute for Advanced Clinical Trials for Children (I-ACT for Children) is excited to announce that Dr. Collin Hovinga has joined the organization as the Senior Vice President, Clinical and Scientific Development. Dr. Hovinga is recognized as a thought leader in pediatric pharmacology and has held appointments with the FDA’s Peripheral and Central Nervous System…

Over the past three months, I-ACT for Children has welcomed three new members to its team. These new members will support the growth of our network sites and management ongoing projects: Laura Lopez will be supporting and developing internal processes as the Assistant Director, Executive Administration and Office Management. Stephen McConoughey will be working in project…

The Institute for Advanced Clinical Trials for Children (I-ACT for Children) is pleased to announce that Elizabeth Garofalo, MD has joined the Institute as a Member of its Board of Directors. Dr. Garofalo was previously the Senior Vice President at Novartis Pharmaceuticals Corporation with a > 25-year career in drug development.  She has participated in…